Company: LNAI
Filing Date: 2025-10-15
Form Type: DEF 14A
Source: 0001731122-25-001378
Chunk: 1

Company: Lunai Bioworks Inc.
Filing Date: 2025-10-15
Form: DEF 14A
Chunk 1
---
 be entitled to vote at the Annual Meeting
and any adjournments, continuations or postponements thereof that may take place. We are holding the Annual Meeting for the following
purposes, which are more fully described in the accompanying proxy statement:

| 1. 
 2. 
 3. 
 4. | To elect four directors to serve until the Company’s 2026 annual meeting of stockholders or until their successors are duly elected and qualified (“Election of Directors”);                                                                         
 To approve by a non-binding advisory vote the compensation of the Company’s named executive officers, as disclosed in this proxy statement (the “Say-on-Pay Proposal”);                                                                              
 To approve by a non-binding advisory vote the appointment of Sadler, Gibb & Associates LLC (“Sadler”) as the Company’s independent registered public accounting firm for the fiscal year ending June 30, 2026 (the “Auditor Ratification Proposal”); 
 To approve proposed amendments to the Renovaro Biosciences, Inc. 2023 Equity Incentive Plan, as amended, in substantially the form attached to the proxy statement as Annex A (the “Incentive Plan Proposal”); and                                   |
|:---|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 5. | To transact such other business that is properly presented at the Annual Meeting.                                                                                                                                                                    |

Stockholders are referred to the
proxy statement accompanying this notice for more detailed information with respect to the matters to be considered at the Annual Meeting.
After careful consideration, the Board has determined that each proposal listed above is in the best interests of the Company and its
stockholders and has approved each proposal. The Board recommends a vote FOR each of the Board’s four nominees that are standing for election to the board of directors (Proposal 1), FOR the Say-on-Pay Proposal (Proposal 2), FOR the Auditor Ratification Proposal (Proposal 3), and FOR the Incentive Plan Proposal (Proposal 4).

The Board has fixed the close of
business on October 3, 2025 as the Record Date for the Annual Meeting. Only stockholders of record on the Record Date are entitled to
receive notice of the Annual Meeting and to vote at the Annual Meeting or at any postponement(s), continuations(s), or adjournment(s)
of the Annual Meeting. A complete list of registered stockholders entitled to vote at the Annual Meeting will be available for inspection
at our offices during regular business hours for the 10 calendar days